Mild cognitive impairment: Ten years later

Ronald Carl Petersen, Rosebud O Roberts, David S Knopman, Bradley F Boeve, Yonas Endale Geda, Robert J. Ivnik, Glenn E. Smith, Clifford R Jr. Jack

Research output: Contribution to journalArticle

765 Citations (Scopus)

Abstract

In the past 10 years, there has been a virtual explosion in the literature concerning the construct of mild cognitive impairment. The interest in this topic demonstrates the increasing emphasis on the identification of the earliest features of cognitive disorders such as Alzheimer disease and other dementias. Mild cognitive impairment represents the earliest clinical features of these conditions and, hence, has become a focus of clinical, epidemiologic, neuroimaging, biomarker, neuropathological, disease mechanism, and clinical trials research. This review summarizes the progress that has been made while also recognizing the challenges that remain.

Original languageEnglish (US)
Pages (from-to)1447-1455
Number of pages9
JournalArchives of Neurology
Volume66
Issue number12
DOIs
StatePublished - Dec 2009

Fingerprint

Explosions
Neuroimaging
Dementia
Alzheimer Disease
Biomarkers
Clinical Trials
Research
Cognitive Dysfunction
Mild Cognitive Impairment
Alzheimer's Disease

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Mild cognitive impairment : Ten years later. / Petersen, Ronald Carl; Roberts, Rosebud O; Knopman, David S; Boeve, Bradley F; Geda, Yonas Endale; Ivnik, Robert J.; Smith, Glenn E.; Jack, Clifford R Jr.

In: Archives of Neurology, Vol. 66, No. 12, 12.2009, p. 1447-1455.

Research output: Contribution to journalArticle

@article{6a94fa922f6e4552b4635ef2c07b90e6,
title = "Mild cognitive impairment: Ten years later",
abstract = "In the past 10 years, there has been a virtual explosion in the literature concerning the construct of mild cognitive impairment. The interest in this topic demonstrates the increasing emphasis on the identification of the earliest features of cognitive disorders such as Alzheimer disease and other dementias. Mild cognitive impairment represents the earliest clinical features of these conditions and, hence, has become a focus of clinical, epidemiologic, neuroimaging, biomarker, neuropathological, disease mechanism, and clinical trials research. This review summarizes the progress that has been made while also recognizing the challenges that remain.",
author = "Petersen, {Ronald Carl} and Roberts, {Rosebud O} and Knopman, {David S} and Boeve, {Bradley F} and Geda, {Yonas Endale} and Ivnik, {Robert J.} and Smith, {Glenn E.} and Jack, {Clifford R Jr.}",
year = "2009",
month = "12",
doi = "10.1001/archneurol.2009.266",
language = "English (US)",
volume = "66",
pages = "1447--1455",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Mild cognitive impairment

T2 - Ten years later

AU - Petersen, Ronald Carl

AU - Roberts, Rosebud O

AU - Knopman, David S

AU - Boeve, Bradley F

AU - Geda, Yonas Endale

AU - Ivnik, Robert J.

AU - Smith, Glenn E.

AU - Jack, Clifford R Jr.

PY - 2009/12

Y1 - 2009/12

N2 - In the past 10 years, there has been a virtual explosion in the literature concerning the construct of mild cognitive impairment. The interest in this topic demonstrates the increasing emphasis on the identification of the earliest features of cognitive disorders such as Alzheimer disease and other dementias. Mild cognitive impairment represents the earliest clinical features of these conditions and, hence, has become a focus of clinical, epidemiologic, neuroimaging, biomarker, neuropathological, disease mechanism, and clinical trials research. This review summarizes the progress that has been made while also recognizing the challenges that remain.

AB - In the past 10 years, there has been a virtual explosion in the literature concerning the construct of mild cognitive impairment. The interest in this topic demonstrates the increasing emphasis on the identification of the earliest features of cognitive disorders such as Alzheimer disease and other dementias. Mild cognitive impairment represents the earliest clinical features of these conditions and, hence, has become a focus of clinical, epidemiologic, neuroimaging, biomarker, neuropathological, disease mechanism, and clinical trials research. This review summarizes the progress that has been made while also recognizing the challenges that remain.

UR - http://www.scopus.com/inward/record.url?scp=73549084727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73549084727&partnerID=8YFLogxK

U2 - 10.1001/archneurol.2009.266

DO - 10.1001/archneurol.2009.266

M3 - Article

C2 - 20008648

AN - SCOPUS:73549084727

VL - 66

SP - 1447

EP - 1455

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 12

ER -